The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
New support from the MacMillan Family Foundation will address the urgent need for targeted interventions and community-driven solutions for disparities in cancer care.
HICCC members will present their innovative research and be recognized for their significant scientific contributions in the field of cancer research at the ASCO Annual meeting.
Lewis Silverman, MD will join the Department of Pediatrics as director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Transplantation.
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
A multi-institution team of lung cancer experts have received a new SU2C grant to bring technology-enabled immunotherapy monitoring to under-represented patients.
The American Society of Clinical Oncology (ASCO) and Conquer Cancer Foundation have recognized seven leading oncology trainees from Columbia Cancer with Young Investigator Awards and Merit Awards.
Michael Shen, PhD, the Arthur J. Antenucci Professor of Medical Sciences, has been elected to the 2021 class of new fellows of the American Association for the Advancement of Science (AAAS).
Dr. Barbara Pro, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center (HICCC).
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.